Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dominion Energy Inc (D) vs Cassava Sciences Inc (FLNA) Price & Performance

Dominion Energy IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Dominion Energy Inc vs Cassava Sciences Inc — how do they compare? Dominion Energy Inc trades at $61.71 (market cap $54.31B), while Cassava Sciences Inc trades at $0.82 (market cap $39.40M). The key difference: Dominion Energy Inc is far larger — about 1378.4× Cassava Sciences Inc's market cap, and Dominion Energy Inc pays a 4.32% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Cassava Sciences Inc for 37 Days on average.

DFLNA
Market Cap
$54.31B$39.40M
Volume
6,944,775759,018
Sector
UtilitiesHealth
52-Week High
$71.67$4.64
52-Week Low
$57.08$0.68
Typical Hold Time
76 Days37 Days
Enterprise Value
$108.43B-$43.28M
Dividend Yield
4.32%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dominion Energy Inc

Dominion Energy (D) trades at $61.53, down 0.76% on the day, with a bearish technical signal driven by moving averages and ADX. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending, and maintains solid profitability with a net income margin of 13.99%. Recent news highlights a proposed merger with NextEra Energy, which could reshape its strategic direction.

The stock offers a consensus price target of $71.56, implying potential upside, supported by a dividend yield. Key risks include execution of the merger, high debt levels, and interest rate sensitivity. Analyst sentiment is mixed with a Hold majority, reflecting cautious optimism amid transformative corporate actions.

Cassava Sciences Inc

FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.

The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

D

No sentiment data available yet.

FLNA
73% Buy27% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Dominion Energy Inc

Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.

Read more on D →

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →